Raymond James Trust N.A. Purchases 284 Shares of Xylem Inc. (NYSE:XYL)

Raymond James Trust N.A. boosted its position in Xylem Inc. (NYSE:XYL) by 14.8% during the third quarter, according to its most recent 13F filing with the SEC. The firm owned 2,200 shares of the industrial products company’s stock after acquiring an additional 284 shares during the period. Raymond James Trust N.A.’s holdings in Xylem were worth $297,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Cetera Investment Advisers grew its holdings in Xylem by 191.7% during the 1st quarter. Cetera Investment Advisers now owns 27,412 shares of the industrial products company’s stock valued at $3,543,000 after buying an additional 18,014 shares in the last quarter. Victory Capital Management Inc. grew its stake in Xylem by 9.3% during the third quarter. Victory Capital Management Inc. now owns 1,627,279 shares of the industrial products company’s stock valued at $219,731,000 after acquiring an additional 137,883 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Xylem by 0.4% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,345,768 shares of the industrial products company’s stock worth $181,719,000 after acquiring an additional 5,817 shares during the period. Quintet Private Bank Europe S.A. lifted its stake in Xylem by 28.0% in the 3rd quarter. Quintet Private Bank Europe S.A. now owns 203,262 shares of the industrial products company’s stock worth $27,446,000 after purchasing an additional 44,414 shares in the last quarter. Finally, Banque Cantonale Vaudoise boosted its holdings in Xylem by 13.9% in the 3rd quarter. Banque Cantonale Vaudoise now owns 42,713 shares of the industrial products company’s stock valued at $5,768,000 after purchasing an additional 5,209 shares during the period. 87.96% of the stock is owned by hedge funds and other institutional investors.

Xylem Stock Up 0.9 %

Shares of NYSE:XYL opened at $125.60 on Thursday. The stock has a market capitalization of $30.51 billion, a P/E ratio of 36.73, a price-to-earnings-growth ratio of 2.37 and a beta of 1.05. The stock’s 50-day moving average price is $129.89 and its 200-day moving average price is $134.00. The company has a current ratio of 1.96, a quick ratio of 1.42 and a debt-to-equity ratio of 0.19. Xylem Inc. has a 12-month low of $102.63 and a 12-month high of $146.08.

Xylem (NYSE:XYL) last posted its quarterly earnings results on Thursday, October 31st. The industrial products company reported $1.11 earnings per share (EPS) for the quarter, hitting the consensus estimate of $1.11. The business had revenue of $2.10 billion for the quarter, compared to analyst estimates of $2.17 billion. Xylem had a return on equity of 9.61% and a net margin of 9.85%. Xylem’s revenue for the quarter was up .2% compared to the same quarter last year. During the same period last year, the company earned $0.99 EPS. On average, equities analysts anticipate that Xylem Inc. will post 4.23 earnings per share for the current year.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 24th. Shareholders of record on Tuesday, November 26th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 1.15%. The ex-dividend date is Tuesday, November 26th. Xylem’s dividend payout ratio (DPR) is presently 42.11%.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on XYL shares. Royal Bank of Canada lowered their price objective on Xylem from $163.00 to $162.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. Robert W. Baird dropped their price target on Xylem from $175.00 to $154.00 and set an “outperform” rating for the company in a research report on Friday, November 1st. UBS Group assumed coverage on shares of Xylem in a research report on Tuesday, August 13th. They issued a “buy” rating and a $165.00 price objective on the stock. Stifel Nicolaus lifted their target price on shares of Xylem from $170.00 to $172.00 and gave the company a “buy” rating in a research report on Wednesday, July 31st. Finally, TD Cowen decreased their price target on shares of Xylem from $138.00 to $125.00 and set a “hold” rating on the stock in a report on Wednesday, November 6th. Four equities research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $149.64.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.